Clinical Trial Update: Glucose-dependent Insulinotropic Polypeptide - New Role as Blood Glucose Stabilizer? [Phase 1, Phase 2]

View source ↗

Summary

This update reports on a Phase 1/Phase 2 study evaluating glucose-dependent insulinotropic peptide (GIP) as a potential blood glucose stabilizer in diabetes. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• glucose-dependent insulinotropic peptide (GIP) (glucose-dependent insulinotropic peptide)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED